Growth Metrics

Corcept Therapeutics (CORT) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 20.11%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 14.71%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 31.42%
10 Corcept Therapeutics 7.26 Bn 6.92 Bn 162.02 Mn -38.45%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -38.45%
Dec 31, 2025 4.80%
Sep 30, 2025 17.84%
Jun 30, 2025 34.90%
Mar 31, 2025 -49.03%
Dec 31, 2024 6.68%
Sep 30, 2024 13.86%
Jun 30, 2024 -2.67%
Mar 31, 2024 -2.07%
Dec 31, 2023 -45.76%
Sep 30, 2023 21.16%
Jun 30, 2023 -7.41%
Mar 31, 2023 -7.90%
Dec 31, 2022 -11.62%
Sep 30, 2022 -4.43%
Jun 30, 2022 -10.51%
Mar 31, 2022 14.58%
Dec 31, 2021 32.12%
Sep 30, 2021 2.97%
Jun 30, 2021 42.92%
Mar 31, 2021 -9.70%
Dec 31, 2020 11.70%
Sep 30, 2020 39.96%
Jun 30, 2020 51.22%
Mar 31, 2020 52.06%
Dec 31, 2019 120.71%
Sep 30, 2019 62.77%
Jun 30, 2019 151.38%
Mar 31, 2019 92.67%
Dec 31, 2018 72.37%
Sep 30, 2018 269.26%
Jun 30, 2018 380.56%
Mar 31, 2018 175.76%
Dec 31, 2017 170.15%
Sep 30, 2017 56.38%
Jun 30, 2017 54.69%
Mar 31, 2017 41.72%
Dec 31, 2016 37.21%
Sep 30, 2016 44.55%
Jun 30, 2016 29.49%
Mar 31, 2016 31.67%
Dec 31, 2015 35.27%
Sep 30, 2015 27.96%
Jun 30, 2015 74.02%
Mar 31, 2015 43.73%
Dec 31, 2014 39.37%
Sep 30, 2014 3.44%
Jun 30, 2014 -7.81%
Mar 31, 2014 -15.26%
Dec 31, 2013 -12.20%
Sep 30, 2013 -10.49%